Swixx Biopharma Acquires Biopas, Expanding its Presence to Latin America

Share this
Swixx Biopharma


Swixx Biopharma Acquires Biopas, Expanding its Presence to Latin America


  • Swixx BioPharma has agreed to acquire 100% of Pharma Consulting Group’s equity, the holding company of Laboratorios Biopas, to expand its reach into Latin America
  • Through the acquisition, the company will have its presence in Latam’s Top 5 markets incl. Argentina, Brazil, Chile, Colombia & Mexico. The transaction is anticipated to conclude in Jun-Jul 2024 post certain regulatory approvals
  • Following its Middle East entry in Sep 2023, Swixx BioPharma's acquisition of Biopas enhances its aim of becoming biopharma companies’ preferred partner. The expansion further covers Central & Eastern EU, CIS/Eurasia, MENA & Latin America. Biopas will retain its name and leadership team in Latin America, despite becoming part of Swixx BioPharma

Ref: Swixx Biopharma | Image: Swixx Biopharma

Related News:- Acorda Therapeutics Entered into Distribution and Supply Agreements with Biopas to Commercialize Inbrija in Latin America for Parkinson's Disease

PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com

Click here to­ read the full press release 

Disha Nankani

Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions